CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $0.88 (-0.35%) -48.24% +13.51% -61.74
17/03/2014 FNV.US 4 out of 5 Outperform 5Y $51.81 $52.75 (-0.32%) +1.82% +13.51% -11.69
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.81 (+1.25%) -58.25% +13.51% -71.76
17/03/2014 GDXJ.US 4 out of 5 Outperform 5Y $44.00 $26.57 (+0.76%) -39.61% +13.51% -53.12
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $33.93 $32.15 (+0.12%) -5.26% +13.51% -18.77
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $1.00 (-2.91%) -84.30% +13.51% -97.81
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.86 $21.98 (+1.10%) -21.10% +13.51% -34.61
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $380.16 (-1.21%) +111.55% +53.39% -58.17
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $2.36 (+2.61%) -62.00% +40.70% -102.70
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $4.50 (+4.41%) +0.67% +38.83% -38.16
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $15.93 $9.68 (+0.99%) -39.26% +38.83% -78.09
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $3.33 (+0.60%) +4.06% +40.11% -36.05
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.42 (-4.04%) -90.93% +40.11% -131.04
04/02/2013 SSRI.US 5 out of 5 Outperform 5Y $12.09 $5.26 (-0.75%) -56.49% +40.14% -96.63
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $12.46 $3.46 (+1.17%) -72.24% +40.14% -112.38
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.32 (+3.98%) -87.30% +41.24% -128.54
23/01/2013 NRT.US 5 out of 5 Outperform 1Y $20.75 $14.05 (+0.29%) -32.30% +41.26% -73.56
23/01/2013 POT.US 5 out of 5 Outperform 5Y $38.52 $35.90 (+0.87%) -6.80% +41.26% -48.06
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $7.32 (-1.08%) +40.23% +41.26% -1.03
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.45 (+3.81%) -76.85% +43.41% -120.26
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.